MorphoSys AG
XETRA:MOR

Watchlist Manager

MorphoSys AG

XETRA:MOR

Watchlist

Dividends

Price: 67.25 EUR 0.37% Market Closed

Market Cap: 2.5B EUR

Have any thoughts about
MorphoSys AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 67.25 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MOR Alert

MorphoSys AG

67.25

+0.25 (+0.37%)

52 Week Range	16.35 69.35
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

MorphoSys AG

What unique competitive advantages
does MorphoSys AG hold over its rivals?

What risks and challenges
does MorphoSys AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of MorphoSys AG.

What unique competitive advantages
does MorphoSys AG hold over its rivals?

What risks and challenges
does MorphoSys AG face in the near future?

Has there been any significant insider trading activity
in MorphoSys AG recently?

Summarize the latest earnings call
of MorphoSys AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MorphoSys AG.

Provide P/S
for MorphoSys AG.

Provide P/E
for MorphoSys AG.

Provide P/OCF
for MorphoSys AG.

Provide P/FCFE
for MorphoSys AG.

Provide P/B
for MorphoSys AG.

Provide EV/S
for MorphoSys AG.

Provide EV/GP
for MorphoSys AG.

Provide EV/EBITDA
for MorphoSys AG.

Provide EV/EBIT
for MorphoSys AG.

Provide EV/OCF
for MorphoSys AG.

Provide EV/FCFF
for MorphoSys AG.

Provide EV/IC
for MorphoSys AG.

Show me price targets
for MorphoSys AG made by professional analysts.

What are the Revenue projections
for MorphoSys AG?

How accurate were the past Revenue estimates
for MorphoSys AG?

What are the Net Income projections
for MorphoSys AG?

How accurate were the past Net Income estimates
for MorphoSys AG?

What are the EPS projections
for MorphoSys AG?

How accurate were the past EPS estimates
for MorphoSys AG?

What are the EBIT projections
for MorphoSys AG?

How accurate were the past EBIT estimates
for MorphoSys AG?

Compare the revenue forecasts
for MorphoSys AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MorphoSys AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MorphoSys AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of MorphoSys AG compared to its peers.

Compare the P/E ratios
of MorphoSys AG against its peers.

Discuss the investment returns and shareholder value creation
comparing MorphoSys AG with its peers.

Analyze the financial leverage
of MorphoSys AG compared to its main competitors.

Show all profitability ratios
for MorphoSys AG.

Provide ROE
for MorphoSys AG.

Provide ROA
for MorphoSys AG.

Provide ROIC
for MorphoSys AG.

Provide ROCE
for MorphoSys AG.

Provide Gross Margin
for MorphoSys AG.

Provide Operating Margin
for MorphoSys AG.

Provide Net Margin
for MorphoSys AG.

Provide FCF Margin
for MorphoSys AG.

Show all solvency ratios
for MorphoSys AG.

Provide D/E Ratio
for MorphoSys AG.

Provide D/A Ratio
for MorphoSys AG.

Provide Interest Coverage Ratio
for MorphoSys AG.

Provide Altman Z-Score Ratio
for MorphoSys AG.

Provide Quick Ratio
for MorphoSys AG.

Provide Current Ratio
for MorphoSys AG.

Provide Cash Ratio
for MorphoSys AG.

What is the historical Revenue growth
over the last 5 years for MorphoSys AG?

What is the historical Net Income growth
over the last 5 years for MorphoSys AG?

What is the current Free Cash Flow
of MorphoSys AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for MorphoSys AG.

P/FCFE
Price to FCFE

-8.2

Current

-2.3

Median

25.2

Industry

Lower than median

Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE

-8.2

Market Cap

2.5B EUR

FCFE

-307.5m EUR

All Countries

Forward Multiples

			Market Cap	P/FCFE
DE		MorphoSys AG XETRA:MOR	2.5B EUR	-8.2
FR		Pharnext SCA OTC:PNEXF	6T USD	-3 227 395.3
US		Abbvie Inc NYSE:ABBV	312.7B USD	12.5
US		Amgen Inc NASDAQ:AMGN	158.3B USD	26.7
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	-87.8
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	11.2
US	E	Epizyme Inc F:EPE	94.1B EUR	-425.2
AU		CSL Ltd ASX:CSL	133.6B AUD	79
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	24.5
US	S	Seagen Inc F:SGT	39.3B EUR	-58.5
NL		argenx SE XBRU:ARGX	34.8B EUR	-109.8


DE		MorphoSys AG XETRA:MOR	Average P/FCFE: 30.8 Negative Multiple: -8.2
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -3 227 395.3
US		Abbvie Inc NYSE:ABBV	12.5
US		Amgen Inc NASDAQ:AMGN	26.7
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -87.8
US		Gilead Sciences Inc NASDAQ:GILD	11.2
US	E	Epizyme Inc F:EPE	Negative Multiple: -425.2
AU		CSL Ltd ASX:CSL	79
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	24.5
US	S	Seagen Inc F:SGT	Negative Multiple: -58.5
NL		argenx SE XBRU:ARGX	Negative Multiple: -109.8

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/FCFE

N/A

2-Years Forward

P/FCFE

N/A

3-Years Forward

P/FCFE

N/A

MorphoSys AG
XETRA:MOR

P/FCFE
Price to FCFE

P/FCFE Forward Multiples

See Also

Company

Help

Tools

Stocks

MorphoSys AG XETRA:MOR

P/FCFE Price to FCFE

P/FCFE Forward Multiples

See Also

Company

Help

Tools

Stocks

MorphoSys AG
XETRA:MOR

P/FCFE
Price to FCFE